Impilo
Finance · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Regeringsgatan 48, Stockholm, Stockholm,...Phone Number
+46 84010060Website
www.impilo.seRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
1
2
1
About Impilo
Impilo AB is a company that operates in the Investment Banking industry. It employs 20to49 people and has 5Mto10M of revenue. The company is headquartered in Stockholm, Stockholm, Sweden.Explore more
Impilo Org Chart
BM
Data Entry Clerk
MM
Certified Nursing Assistant
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Impilo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Impilo had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Impilo has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Impilo launches new products
Earning: See what the market has to say on Impilo recently announced quarterly report
Check out if Impilo is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Impilo
Impilo, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Impilo has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Impilo as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Impilo is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Impilo is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Impilo.
Impilo Tech Stack
A closer look at the technologies used by Impilo
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Left Company
Executive Move
Executive Moves, Left Company
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
Impilo News & Media
Leading global investment firm KKR and Nordic healthcare investment firm Impilo enters strategic partnership together with Immedica management
Stockholm, April 23, 2024 –Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma. Existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. The transaction is subject to customary regulatory and closing conditions. KKR and Impilo will work together with Immedica’s management team to support Immedica’s continued growth, including the launch of the recently approved ultra-orphan drug Loargys,KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma
STOCKHOLM & LONDON--(BUSINESS WIRE)--Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. The transaction is subject to customary regulatory and closing conditions. KKR and ImpiloImpilo invests in Avia Pharma – a leading OTC and Rx pharmaceutical platform
STOCKHOLM, Sweden, 2 February 2024 – Impilo has closed its investment in Avia Pharma Holding AB (“Avia” or the “Company”), a Sweden-based OTC and Rx pharmaceutical company with presence in the Nordics and Germany. Continuing on Impilo’s long-term ambitions of building a leading Northern European OTC/Rx platform, and the work through Mallax, Impilo now partners with two of the co-founders and management of Avia. Our ambition is to build a leading Northern European OTC / RxStille carries out a directed share issue of approximately SEK 425 million
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. The board of directors of
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Impilo
Sign Up For FreeTo access detailed company insights
Impilo AB is a company that operates in the Investment Banking industry. It employs 20to49 people and has 5Mto10M of revenue. The company is headquartered in Stockholm, Stockholm, Sweden.... Read More
